Both in Biotechnology
BioCryst Pharmaceuticals vs Recursion Pharmaceuticals
Over the past year BCRX returned +24.9% and RXRX returned −32.4%; their daily moves had a correlation of 0.20.
BCRX +24.9% RXRX −32.4%Growth of $1, one year, split-adjusted
| Metric | BCRX | RXRX |
|---|---|---|
| Price | $8.57 | $3.68 |
| Market cap | $2.19B | $2.20B |
| Today | +3.94% | −3.92% |
| 1 month | +5.8% | −23.0% |
| 6 months | −5.1% | +9.2% |
| Year to date | +9.9% | −10.0% |
| 1 year | +17.1% | −33.3% |
| Revenue growth (YoY) | +33.6% | +258.5% |
| Gross margin | 98.2% | 45.9% |
| Net margin | 35.9% | −641.6% |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | 32.2× |
| Net cash | -$471.6M | $538.0M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 95.4% |
| Short % of float | 10.9% | 37.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).